Ronald Blue Trust, Inc. Sarepta Therapeutics, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 568 shares of SRPT stock, worth $71,431. This represents 0.0% of its overall portfolio holdings.
Number of Shares
568
Previous 57
896.49%
Holding current value
$71,431
Previous $9,000
677.78%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SRPT
# of Institutions
530Shares Held
84.5MCall Options Held
2.06MPut Options Held
1.52M-
Black Rock Inc. New York, NY10.3MShares$1.3 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.97MShares$1.13 Billion0.02% of portfolio
-
Capital International Investors Los Angeles, CA6.26MShares$787 Million0.16% of portfolio
-
Janus Henderson Group PLC London, X04.36MShares$548 Million0.29% of portfolio
-
State Street Corp Boston, MA4.27MShares$537 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...